Clinical Trial Update: Efficacy Study Comparing Velcade Dexamethasone Thalidomide Versus Velcade Cyclophosphamide Dexamethasone as Induction Treatment in the Initial Management of Multiple Myeloma (IFM2013-04) [Phase 3]

View source ↗

Summary

This Phase 3 trial update reports completion of a study comparing Velcade-based induction regimens with dexamethasone and thalidomide versus Velcade with dexame…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Thalomid (thalidomide)
• Velcade (bortezomib)

Snippet

Sponsor: Nantes University Hospital | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED